HEIDELBERG PHARMA AG O.N./ DE000A11QVV0 /
26/04/2024 21:41:18 | Diferencia -0.0300 | Volumen | Bid21:41:19 | Ask21:41:19 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.9100EUR | -1.02% | 0 Volumen de negocios: 0.0000 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 101.5 millonesEUR | 0.00% | - |
Newsfile Corp
27/04
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages SSR Mining Inc. Investors to Secure Counsel Before Import...
GlobeNewswire
27/04
ROSEN, LEADING INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
27/04
GDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors...
GlobeNewswire
27/04
ADSK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Autodesk, Inc. Investors with S...
Newsfile Corp
27/04
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Secure Counsel Befo...
GlobeNewswire
27/04
ROSEN, A LEADING LAW FIRM, Encourages PowerSchool Holdings, Inc. Investors to Inquire About Securiti...
GlobeNewswire
27/04
ROSEN, A TOP RANKED LAW FIRM, Encourages Rivian Automotive, Inc. Investors to Secure Counsel Before ...
GlobeNewswire
27/04
ROSEN, LEADING TRIAL ATTORNEYS, Encourages QuidelOrtho Corporation Investors to Secure Counsel Befor...
GlobeNewswire
27/04
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Compass Minerals International, Inc. Investors to ...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página